Back    Zoom +    Zoom -
<Research>China Renaissance Securities Drops BUD APAC (01876.HK) TP to $11.6, Expects 4Q24 CN Biz to Continue to Be Affected by Macro Econ Impact
Recommend
4
Positive
5
Negative
4
BUD APAC (01876.HK)'s China business is facing multiple challenges in 4Q24, according to a research report published by China Renaissance Securities.

The Company's sales volume in China was negatively impacted by the Company's de-stocking efforts during the period to maintain healthy channel inventory levels, as well as a weak performance of the ready-to-drink channel, Management said.

Related NewsJPM Cuts BUD APAC's TP to $8.4, Rates Neutral
BUD APAC's normalized EBITDA margin is expected to deteriorate YoY in 4Q24 as a result of the challenges posed by China's macro-economic environment, lower operating efficiencies due to the reduction in BUD APAC's sales volumes and lower cost efficiencies due to the beginning of the stabilization or rebound of the prices of key raw materials, according to the report.

Therefore, the broker dropped its target price from $13.15 to $11.6, with rating reiterated at Buy.
AAStocks Financial News